Navigation Links
Vanda Pharmaceuticals Reports Second Quarter 2011 Results
Date:8/4/2011

rketing and distribution support Fanapt® receives; Vanda's ability to successfully commercialize Fanapt® outside of the U.S. and Canada; delays in the completion of Vanda's clinical trials; a failure of Vanda's products, product candidates or partnered products to be demonstrably safe and effective; Vanda's failure to obtain regulatory approval for its products, product candidates or partnered products or to comply with ongoing regulatory requirements; a lack of acceptance of Vanda's products, product candidates or partnered products in the marketplace, or a failure to become or remain profitable; Vanda's expectations regarding trends with respect to its costs and expenses; Vanda's inability to obtain the capital necessary to fund additional research and development activities; Vanda's failure to identify or obtain rights to new products or product candidates; Vanda's failure to develop or obtain sales, marketing and distribution resources and expertise or to otherwise manage its growth; limitations on Vanda's ability to utilize some or all of its prior net operating losses and research and development credits; a loss of any of Vanda's key scientists or management personnel; losses incurred from product liability claims made against Vanda; a loss of rights to develop and commercialize Vanda's products or product candidates under its license and sublicense agreements and other factors that are described in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of Vanda's annual report on Form 10-K for the fiscal year ended December 31, 2010 which is on file with the SEC and available on the SEC's website at www.sec.gov.  In addition to the risks described above and in Vanda's annual report on Form 10-K and quarterly reports on Form 10-Q, other unknown or unpredictable factors also could affect Vanda's results. There can be no assurance that the actual res
'/>"/>
SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
2. Vanda Pharmaceuticals Reports Third Quarter 2007 Results
3. Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application
4. Vanda Presents Phase III Iloperidone Efficacy Data
5. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
6. Vanda Pharmaceuticals Provides Update on Iloperidone
7. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
8. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
9. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
10. Vanda Pharmaceuticals Announces Expiration of Hart-Scott -Rodino Waiting Period for Exclusive License of Fanapt(TM)
11. Vanda Pharmaceuticals Announces U.S. Patent Allowance for a Long-Acting Injectable Formulation of Fanapt(TM) (iloperidone) in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 18, 2014 Somewhere between dropping five pounds ... forgotten. But Audicus , a next-generation hearing aids ... new year. Hearing loss is the third ... though it is often unaddressed. Forty-eight million Americans have ... hearing aid, mainly due to price. Hearing aids traditionally ...
(Date:12/19/2014)... CITY, Calif., Dec. 18, 2014 Capnia, ... the development of medical diagnostics based on its ... gas flow, today announced financial results for the ... 2014. "Following the completion of our ... positioned to maximize the recently initiated CoSense® commercial ...
(Date:12/19/2014)... KANSAS CITY, Kan. , Dec. 18, 2014 ... PETX ), a biopharmaceutical company focused on ... for companion animals, today announced positive results from ... company,s innovative drug for treating pain in dogs ... demonstrated improvements in pain assessment scores that were ...
Breaking Medicine Technology:Audicus Will Help People Resolve to Hear Better in 2015 2Capnia Reports Third Quarter 2014 Financial Results 2Capnia Reports Third Quarter 2014 Financial Results 3Capnia Reports Third Quarter 2014 Financial Results 4Capnia Reports Third Quarter 2014 Financial Results 5Capnia Reports Third Quarter 2014 Financial Results 6Capnia Reports Third Quarter 2014 Financial Results 7Capnia Reports Third Quarter 2014 Financial Results 8Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5
...  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) today ... 9,500,000 shares of its common stock at a price ... proceeds to Neurocrine from this offering, before deducting underwriting ... Neurocrine, are expected to be approximately $77 million. The ...
... of the Boy Scouts of America announced today that ... Merit Badge requirements through an event hosted by the ... Boy Scout participants will have the chance to interact ... guidance they can participate in activities geared toward badge ...
Cached Medicine Technology:Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock 2Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock 3Catalina Council Boy Scouts Partner With Sanofi US Tucson Research Center to Host First-Ever Chemistry Merit Badge Program 2Catalina Council Boy Scouts Partner With Sanofi US Tucson Research Center to Host First-Ever Chemistry Merit Badge Program 3
(Date:12/22/2014)... FL (PRWEB) December 22, 2014 Coral Gables ... removal service , Lice Troopers, with its new clinic location ... southern Florida, takes the hassle out of dealing with this ... in one of their two salon clinic locations in South ... other location. , The decision to expand developed naturally out ...
(Date:12/22/2014)... December 22, 2014 International ... Ebola virus epidemic are receiving further support ... agencies, nongovernmental organizations (NGOs) and other charitable ... healthcare workers, emergency responders, patients and others ... as the CmTP MediDefense system , ...
(Date:12/22/2014)... Colorado (PRWEB) December 22, 2014 Super ... Black Friday this year as the busiest day in ... other retailers, The Grass Station had a steady pre-Christmas ... holiday gifts, this past Saturday. , “I definitely intend ... 33-year-old Robert, a Denver resident who was enjoying The ...
(Date:12/22/2014)... 22, 2014 The MedTech industry is gearing ... wholly owned subsidiary of PartnerTech AB of Sweden, is prepared ... achieved additional ISO Certification. , All signs point to growth ... the likelihood of a repeal of the excise tax originally ... industry is anticipating annual growth of 9.3% and PartnerTech Inc. ...
(Date:12/22/2014)... December 22, 2014 Luxury Linen purveyor ... Partners of Dallas to provide logistics and support for ... Peacock Alley has a long history of giving back to ... sponsors of this year's Toy Drive were Whataburger® and 99.5 ... back than the holidays. Providing gifts to children who would ...
Breaking Medicine News(10 mins):Health News:Professional In-Home All-Natural Lice Removal Service Expands to Coral Gables and surrounding areas. 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 3Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 4Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 5Health News:Customers at Colorado’s Grass Station Say They’re Enjoying the Experience of Legally Purchasing Marijuana this Year to Give as Christmas Presents to Friends and Family 2Health News:PartnerTech Inc. Poised for Growth in MedTech 2Health News:Peacock Alley and Community Partners of Dallas Fulfill an Estimated 12,000 Holiday Wishes for Deserving Children 2
... 2010 - The 1994 genocide in Rwanda resulted in the ... course of about 100 days. Although the exact death ... of the country,s entire population was murdered. There can ... survivors developed posttraumatic stress disorder, or PTSD, an anxiety disorder ...
... rats, treatment boosts blood vessel and nerve cell growth, researchers ... the results of preliminary research in rats, researchers say that ... could help people recover brain function after a stroke. , ... induced ischemic strokes showed signs of blood vessel growth and ...
... ... on Outsourcing , ... Westborough, MA (PRWEB) February 25, 2010 -- Advans, a solution provider and IT ... popularity of domestic outsourcing. According to the Advans’ IT Outsourcing Survey, 75 percent of ...
... ... Promises New Insight , ... Rosemont, IL (Vocus) February 25, 2010 -- Dr. Robert C. Bray of the ... Society for Sports Medicine’s (AOSSM) $250,000 Ligament and Tendon Repair and Regeneration Grant ...
... ... and overwhelmed state agencies are possible causes for the increase in health care inquiries. ... Cleveland, OH ... health insurance quotes from HealthInsuranceSort. The need for individual health insurance from private ...
... Researchers from the Toronto Western Research Institute noted a ... in the U.S. versus the Canadian population. The authors ... a greater level of obesity and physical inactivity in ... published in the March issue of Arthritis Care ...
Cached Medicine News:Health News:Rwandan genocide survivors provide new insights into resilience and PTSD 2Health News:Vitamin B3 May Help Repair Brain After a Stroke 2Health News:Advans Survey Reveals that 75 Percent of Executives Prefer Domestic Outsourcing vs. Offshore 2Health News:$250,000 Grant Awarded for Groundbreaking Ligament and Tendon Repair Research 2Health News:HealthInsuranceSort.com Provides Record Number of Health Insurance Quotes in 2009 2Health News:Obesity and physical inactivity poses arthritis risk, especially for women 2
For the qualitative detection of cardiac troponin I (cTnl) in human whole blood and serum specimens...
For the qualitative detection of cardiac troponin I (cTnl) in human whole blood and serum specimens...
For the qualitative detection of antibodies to Treponema pallidum in human serum, plasma and whole blood specimens...
For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...
Medicine Products: